MedCline furthers clinical reach to include PPI-refractory, laryngopharyngeal reflux (LPR), post-esophogectomy and gestational GERD patients providing a much-needed solution for those suffering with nocturnal symptoms.
Furthering its commitment to validate its products with compelling clinical data with top researchers nationwide, Amenity Health has widened the clinical applications for its MedCline sleep positioning device to include include PPI-refractory, laryngopharyngeal reflux (LPR), post-esophogectomy and gestational reflux patients. Through 5 clinical trials completed in 2015, MedCline has been shown to be an effective treatment for GERD patients suffering with nocturnal reflux symptoms, including heartburn and regurgitation.
Highlights from these studies include:
The 2015 clinical trials are added to a growing library of clinical data, including the randomized controlled trial conducted by the Medical University of South Carolina published in the June issue of the Journal of Clinical Gastroenterology, which showed:
This article can be found at:
Amenity Health will continue to participate in clinical trials to evaluate MedCline with additional patient applications, such as scleroderma and post-lung transplant patients. For more information about MedCline clinical trial result, contact Aaron Clark at 858-605-1747.